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Abstract Renaturation kinase assay was used to detect protein 
kinases activated by lysophosphatidic acid (LPA) in cultured rat 
3YI fibroblasts. LPA activated several Ser/Thr protein kinases 
with apparent molecular weights of 145K, 85K, 64-65K (a 
doublet), and 60K (each named p145, p85, p64/65 and/760, re- 
spectively) in addition to p43 mitogen activated protein (MAP)- 
kinase. Experiments using pertussis toxin and botulinum C3 
exoenzyme showed that p145, p85, and p64165 kinases were 
activated by a pertussis toxin-insensitive rho p21-dependent pa h- 
way and that the activation of MAP-kinase was mediated by both 
the pertnssis toxin-sensitive rho p21-independent a d the pertus- 
sis toxin-insensitive rho p21-dependent pathways. 
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• [11,12]. We and others have previously demonstrated that LPA 
induced the tyrosine phosphorylation of a variety of proteins 
in cultured cells [13,14]. We further showed that some of these, 
e.g. the phosphorylation fp125 FAK, were significantly atten- 
uated by the C3 exoenzyme-catalyzed ADP-ribosylation of rho 
p21, suggesting that rho p21 served as a transducer linking LPA 
signalling to the tyrosine phosphorylation [15]. A similar find- 
ing has recently been obtained in protein tyrosine phosphoryl- 
ation induced by bombesin and endothelin in Swiss 3T3 cells 
[16]. However, the signalling pathway linking rho p21 to tyro- 
sine phosphorylation has remained elusive. In this study, using 
a renaturation kinase assay [17], we have analyzed protein 
kinase species activated by LPA in cultured cells, and examined 
their sites of activation in the signalling pathway. Our results 
showed that several protein serine/threonine kinases are acti- 
vated by LPA and that some of them appear to be downstream 
of rho p21 in the signal transduction pathway. 
1. Introduction 2. Materials and methods 
Lysophosphatidic a id (LPA) is a platelet derived serum fac- 
tor that evokes a wide range of biological effects, including the 
stimulation offibroblast proliferation, platelet aggregation, cell 
motility, tumor cell invasion and neurite retraction [1]. LPA 
appears to activate its own receptor(s) coupling to both PTX- 
sensitive and insensitive G-proteins. One characteristic re- 
sponse found in fibroblasts is the induction of focal adhesion 
and stress fiber formation, which is mediated by a small molec- 
ular weight GTP-binding protein, rho p21 [2]. rho p21 is a 
member of the ras superfamily of small GTPases. The functions 
of this protein have been examined by the use of botulinum C3 
exoenzyme, which specifically ADP-ribosylates and inactivates 
this protein [3]. Studies using this exoenzyme revealed that rho 
p21 mediates a number of cellular processes, such as stimulus- 
evoked cell adhesion in fibroblasts [2], platelets [4] and lympho- 
cytes [5], cell motility in leukocytes [6] and fibroblasts [7], G1 
to S phase progression of the cell cycle [8], neurite retraction 
stimulated by LPA and thrombin [9], the regulation of smooth 
muscle contraction [10] and cytokinesis during cell division 
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adhesion kinase of 125 KDa; PBS, phosphate-buffered saline; PLC, 
phospholipase C; PKC, protein kinase C; PTX, pertussis toxin; rhop21, 
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2.1. Materials 
[y-32p]ATP (3,000 Ci/mmol) and [~-32p]NAD (800 Ci/mmol) were 
purchased from Dupont New England Nuclear. LPA (1-oleoyl-sn-glyc- 
ero-3-phosphate), phosphoserine, phosphothreonine and phosphoty- 
rosine were obtained from Sigma. LPA was dissolved in 20% ethyl 
alcohol to 20 mM as a stock solution, stored at -80°C and then diluted 
with the serum-free culture medium [13] to 20 I~M before use. PTX (islet 
activating protein from Bordetella pertussis) was obtained from 
Funakoshi Co. Ltd., Tokyo. Lipofectamine was obtained from Life 
Technologies. Recombinant C3 exoenzyme was prepared as previously 
described [15]. All other chemicals used were of reagent grade. 
2.2. Cell culture 
Rat 3Y1 fibroblasts were cultured until near confluency in DMEM 
containing 10% fetal calf serum as described previously [13], and sub- 
jected to either C3 exoenzyme or PTX treatment. The cells were incu- 
bated with or without 10/tg/ml C3 exoenzyme first in complete medium 
for 48 h, and then in the serum-free medium for 12 h, as described [15]. 
To facilitate exoenzyme incorporation, 40/lg of the exoenzyme was 
mixed with 40 H1 of lipofectamine and added to the cells during the 
latter incubation. Alternatively, they were incubated with 20 ng/ml of 
PTX in the serum-free medium for 12 h prior to the LPA stimulation. 
The cells were then incubated with 2/~M LPA for the indicated times 
at 37°C in a CO2 incubator. LPA induced cell response from 20 nM 
in a concentration-dependent ma ner, which reached the maximum at 
2/.tM [13]. After incubation, the cells were rinsed with 4 ml per well of 
ice-cold PBS, and then lysed on ice for 10 min with 400 HI of RIPA 
buffer (20 mM Tris-HC1, pH 7.4, 150 mM NaC1, 15 mM EDTA, 1% 
Triton X-100, 1% sodium deoxycholate and 0.1% SDS) containing 
1 mM phenylmethylsulfonyl fluoride, 10 /~M leupeptin, 100 kU/ml 
aprotinin, 1 mM NaaVO 4, 10 HM Na3MoO 4 and 10 mM NaF. The 
lysates were centrifuged at12,000 xg for 15 min, and the supernatants 
were used for the subsequent analysis. 
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2.3. Renaturation kinase assay 
The supernatants (30/.tg protein each) were subjected to SDS-PAGE 
on an 8% polyacrylamide gel, and the separated proteins were trans- 
ferred to PVDF membranes (Millipore) as described previously [13]. 
Denaturation and renaturation of transferred proteins were performed 
essentially as described by Ferrell and Martin [17]. After renaturation, 
the membrane was blocked with 5% BSA in 30 mM Tris-HC1, pH 7.5, 
at room temperature for 1 h, rinsed and incubated with 20 nM (50 
,uCi/ml) [32p]ATP for 30 min at 30°C in 3 ml of the incubation solution 
(30 mM Tris-HCl, pH 7.5, 10 mM MgC12, 2 mM MnC12). The reaction 
was terminated by adding 100 ml of ice-cold 30 mM Tris-HCl, pH 7.5 
(the rinsing solution). The membrane was then rinsed at room temper- 
ature twice with the rinsing solution, once with a solution containing 
0.05% Tween-20, and then again with the rinsing solution for 10 rain 
per rinse. The membrane was then incubated in 1 N KOH for 10 min 
at room temperature, then incubated twice in 1.7 M acetic acid for 
5 min each and finally rinsed with distilled water several times for 10 
min. The membrane was then dried and subjected to autoradiography. 
In this assay, 32p incorporation i to several bands (see below) in- 
creased linearly for 60 min using cell lysates in the range of 5 80 ¢tg 
protein/lane. 32p incorporation also increased with increasing concen- 
trations of [32P]ATP, and saturated at 100-300 nM with essentially the 
same findings. In some experiments, the cell lysates were subjected to 
immunoprecipitation with the anti-ERK-2 antibody 2Y [13,18], and the 
immunoprecipitates were also analyzed by this assay. 
A 
1 2345 
2.4. Phosphoamino acid analysis 
[32P]Phosphorylated bands on the PVDF membranes were excised 
and were subjected to hydrolysis in 6 N HC1 for 70 min at 105°C as 
previously described [19]. The hydrolysates were lyophylized and sub- 
jected to electrophoresis on cellulose thin layer plates (100 ,urn thick- 
ness) as described [20]. The radioactive spots were visualized by autora- 
diography and/or by a Bioimage analyzer BAS2000 (Fujix, Tokyo). 
2.5. ADP-ribosylation 
After incubation with PTX, C3 exoenzyme or vehicle, the cells were 
rinsed twice with PBS pre-warmed to 37°C, and then incubated with 
1.0% trypsin and 0.02% EDTA in PBS. The dissociated cells were 
collected by centrifugation at800 x g for 3 min, suspended in 100/tl of 
the ADP-ribosylation buffer containing [3zp]NAD plus 50 ng activated 
PTX or 100 ng C3 exoenzyme, and then sonicated. The incubation and 
quantification were carried out as previously described [21,22]. The 
amount of protein was determined by the method of Bradford [23]. 
3. Results and discussion 
We used a renaturat ion kinase assay to examine the protein 
kinases activated in response to LPA in cultured rat 3Y1 cells. 
This method exploits the fact that the enzymatic activity of 
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Fig. 1. Renaturation kinase analysis (A) and phosphoamino acid analysis (B) of LPA-activated kinases in rat 3Y 1 fibroblasts. (A) Cells were incubated 
with 2 tiM LPA for 0 (lane 1), 0.5 (lane 2), 1 (lane 3), 5 (lane 4) and 10 (lane 5) min. Cell lysates were prepared and subjected to the renaturation 
kinase analysis as described under section 2. A typical result from at least five experiments is shown. Shown on the right is an autoradiogram of
the same membrane obtained by shorter exposure, showing the activation of p85 kinase. (B) [3:p]Phosphorylated bands (p145, p85, p64/65, p60 and 
p43) observed in the renaturation kinase analysis as above of cell lysates at 5 rain of LPA stimulation were excised and phosphorylated amino acid 
of each band was analyzed. P-Ser, P-Thr and P-Tyr denote the electrophoretic positions of phosphoserine, phosphothreonine and phosphotyrosine, 
respectively. 
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Fig. 2. Effects of PTX treatment on the LPA-induced kinase activation. 
(A) [32P]ADP-ribosylation of a PTX substrate in lysates from control 
(lane 1) and PTX-treated (lane 2) cells. (B) Renaturation kinase analysis 
of control (lanes 1 3) and PTX-treated (lanes 1' 3') cells stimulated by 
LPA for 0 min (lanes 1 and 1'), 1 min (lanes 2 and 2') and 5 min (lanes 
3 and 3'). 
some protein kinases can be renatured after SDS-PAGE and 
blotting onto the membrane [24] and the fact that protein ki- 
nases are often activated by covalent modification and show 
enhanced autophosphorylation. After serum starvation for 
12 h, 3Y1 cells were stimulated with 2/~M LPA for various 
times, and lysates were prepared and subjected to analysis. As 
shown in Fig. 1 A, LPA increased the activity of several kinases, 
with molecular weights of 145K, 85K, 64-65K (a doublet), 60K 
and 43K, which were tentatively named p145, p85, p64165, p60 
and p43 kinase, respectively. The time course and extent of 
activation appeared to be different for each of these proteins. 
For example, p145 was activated rapidly, reached a peak at 
0.5-1 min and maintained the higher activity than baseline 
through incubation. On the other hand, p85 was activated 
throughout he entire 10 min incubation. The activation of 
p64/65 and p60 was transient, with a peak at 1 min. Transient 
activation was also found for p43, which peaked at 5 min but 
then declined. This time course for p43 was reminiscent of the 
LPA-induced activation of MAP-kinase in Swiss 3T3 cells 
[13,15]. We, therefore, immunoprecipitated hecell lysates with 
an anti-ERK2 antibody, and performed the renaturation kinase 
assay on the precipitates. This procedure specifically precipi- 
tated p43, suggesting that it is the MAP-kinase, ERK-2 (data 
not shown). 
To characterize the reactions catalyzed by these proteins, we 
excised the [32P]phosphorylated bands and subjected them to 
phosphoamino acid analysis. As shown in Fig. 1B, all of the 
bands analyzed yielded either phosphoserine or phosphothre- 
onine but not phosphotyrosine, as the major [32p]phosphoam- 
ino acid. Phosphothreonine was found in p145, and phospho- 
serine was detected in p85 and both in p64/65 and p60. p43 
MAP-kinase showed the increased phosphorylation f threon- 
ine in this analysis. These phosphorylations appeared to be due 
to autophosphorylation, because the omission of BSA from the 
solution did not affect the phosphorylation pattern. These re- 
sults indicate that these kinases are protein serine/threonine 
kinases. This is consistent with a previous tudy reporting that 
this method preferentially detects Ser/Thr kinases [17]. 
Since LPA activates multiple signalling pathways and one of 
them is mediated by G~, [1], PTX was used to examine the 
involvement of this G-protein in the activation of the above 
kinases. As shown in Fig. 2A, the incubation of the cells with 
20 ng/ml PTX overnight completely ADP-ribosylated the en- 
dogenous Gi in the cells. Under these conditions, kinase activa- 
tion as determined by the renaturation assay remained unaf- 
fected except forp43 MAP-kinase (Fig. 2B), suggesting that the 
activation of MAP-kinase occurs at least in part through the 
G~ pathway. These results are consitent with the previous find- 
ing that LPA activated MAP-kinase mostly via Gi [14,25]. 
We next used botulinum C3 exoenzyme and examined the 
involvement of rho p21, because rho p21 functions in the other 
pathway of LPA signalling as a transducer between the PTX- 
insensitive G-protein and cell adhesion [1,2,15]. As shown in 
Fig. 3A, the incubation of the cells with 10/tg/ml of exoenzyme 
induced over 80% ADP-ribosylation of the rho p21 in the cells. 
This resulted in a significant attenuation of the activation of 
p145, p85 and p64/65 kinases. The activation of p43 MAP- 
kinase was partially attenuated at 5 min, whereas p60 kinase 
was only slightly affected (Fig. 3B). 
Thus, we have demonstrated that several protein Ser/Thr 
kinases are activated in LPA signalling and their activation was 
interferred by inactivation of Gi and rho p21. Fig. 4 proposes 
a model for LPA-induced signal transduction pathways consis- 
tent with the previous studies and the present findings. LPA 
evokes a variety of biological actions by acting on its cognate 
receptor, coupling to both PTX-sensitive and insensitive G- 
proteins [1]. The pathway mediated by PTX-insensitive G-pro- 
tein(s) involves PLC and PKC activation, rho p21 appears to 
be activated in this pathway apparently independently of PKC 
activation [25,26]. Three Ser/Thr kinases (p145, p85, and p64/ 
65) are activated ownstream of rho p21, which also mediates 
protein tyrosine phosphorylation fp125 FAK and p72 paxillin 
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Fig. 3. Effects of C3 exoenzyme treatment on the LPA-induced kinase activation. (A) [32p]ADP-ribosylation of rho p21 in control and C3 
exoenzyme-treated cells(lane 1 and 2, respectively). (B)Renaturation kinase analysis of control (lanes 1-3) and C3 exoenzyme-treated (lanes 1'-3') 
cells stimulated by LPA for O min (lanes 1 and 1'), 1 min (lanes 2 and 2') and 5 min (lanes 3 and 3'). The control cells received the same amount 
of lipofectamine. Shown in the right is an autoradiogram obtained by longer exposure of the same membrane, showing the inhibition of the p145 
kinase activation by C3 exoenzyme treatment. 
[15]. (The p72 tyrosine-phosphorylated in response to LPA in 
a rho p21-dependent manner in Swiss 3T3 cells [15] was identi- 
fied as paxillin by immunoprecipitation and immunoblot with 
anti-paxillin antibody (Kumagai, N., Morii, N. and Narumiya, 
S., unpublished observation)). This pathway leads to focal ad- 
hesion, stress fiber formation and activation of PI-3-kinase 
[ 15,16,25]. The PTX-sensitive pathway activates ras p21, which 
in turn activates a kinase cascade involving raf kinase, MEK 
and MAP-kinase, leading to cell proliferation [27,28]. MAP- 
kinase is also activated by the rho p21-dependent pathway, 
which contributes to the late phase of its activation [15]. These 
results trongly indicate that rho p21 directly or indirectly acti- 
vates the Ser/Thr kinases, which may form a kinase cascade 
further downstream. It has already been reported that the rho 
p21-related proteins rae and CDC42p21s, but not rhop21 itself, 
activate the Ser/Thr protein kinase PAK and the tyrosine ki- 
nase ACK [29,30]. Hence, rho p21 may activate analogous ki- 
nases. The activation of the Ser/Thr kinases by rho p21 may be 
linked to p125 FAK activation, because FAK undergoes serine 
as well as tyrosine phosphorylation upon cell stimulation [31]. 
It is also possible that the above kinases function in the signal 
transduction of integrin-rnediated c ll adhesion, because rho 
p21 activates integrin to induce cell adhesion to the substratum 
[2,4,5]. Recently, Chen et al. [32] reported that the integrin- 
mediated cell adhesion to the substratum can cause the activa- 
tion of MAP-kinase. It is interesting tonote that MAP-kinase 
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Fig. 4. A model of rho p21 action in the LPA signalling pathways. 
PKC 
activation is mediated by both ras p21 and rho p21-dependent 
pathways, and that the rho p21-dependent pathway contributes 
to the late phase of MAP-kinase activation (this study, and 
[15]). Finally, the findings obtained in the present study may not 
be limited to 3Y1 fibroblasts and LPA signalling, but may be 
applicable to similar transduction pathways in other types of 
cells. We have already obtained the essentially identical results 
in cultured Swiss 3T3 cells (data not shown). Furthermore, 
Ferrell and Martin [33] used the same method and found that 
a group of Ser/Thr kinases were activated in response to throm- 
bin in platelets, several of which appear to overlap with the 
kinases found here. In summary, using the renaturation kinase 
assay, we have identified several Ser/Thr kinases activated in 
fibroblasts in response to LPA and found that some of them 
are mediated by rho p21 in the cell. This is the first report 
showing the link between rho p21 and Ser/Thr kinases, and 
should facilitate identification of the thus far unknown signal 
transduction of this small molecular weight GTP-binding pro- 
tein. 
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